Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 697-708

  Van Der Staay, F Josef ^a,b   Hinz, Volker Ch ^a   Schmidt, Bernard H ^a  

^a Troponwerke   (Germany)

^b MEDA Manufacturing GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DICHLORVOS; DONEPEZIL; METRIFONATE; PARAOXON; PHYSOSTIGMINE; TACRINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINESTERASE INHIBITION; COGNITION; CONFORMATIONAL TRANSITION; DOSE RESPONSE; DRUG CONFORMATION; DRUG EFFECT; DRUG TRANSFORMATION; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; DICHLORVOS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; MALE; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR; REACTION TIME; TRICHLORFON;

EID: 0030440897     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. ADEN ABDI, Y. AND VILLÉN, T.: Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood. Pharmacol. Toxicol. 68: 137-139, 1991.
2. AALTONEN, M., RIEKKINEN, P., SIRVIÖ, J. AND RIEKKINEN, P. J.: Effects of THA on passive avoidance and spatial performance in quisqualic acid nucleus basalis-lesioned rats. Pharmacol. Biochem. Behav. 39: 563-667, 1991.
3. AMERICAN PSYCHIATRIC ASSOCIATION. DSM-III-R: Diagnostic and Statistical Manual III (3rd ed., revised). APA Press, Washington D.C., 1987.
4. ANDERSON, A.: Japan faces the old old problem. Nature (Lond.) 321: 553, 1986.
5. BECKER, R. E. AND GIACOBINI, E.: Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: Clinical, pharmacological, and therapeutic aspects. Drug Dev. Res. 12: 163-195, 1988.
6. BIERER, L. M., HAROUTUNIAN, V., GABRIEL, S., KNOTT, P. J., CARLIN, L. S., PUROHIT, D. P., PERL, D. P., SCHMEIDLER, J., KANOF, P. AND DAVIS, K. L.: Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficit. J. Neurochem. 64: 749-760, 1995.
7. BLOKLAND, A., HINZ, V. AND SCHMIDT, B. H.: Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: Evaluation of the efficacy/ safety profile in rats. Drug Dev. Res. 36: 166-177, 1995.
8. BRODY, J. A.: Prospects for an ageing population. Nature (Lond.), 315: 463-466, 1985.
9. CHAN, P. C. AND PETERS, A. C.: Thirteen week subchronic feed study on trichlorfon in Fischer rats and B6C3F1 mice. Proc. Am. Assoc. Cancer Res. 30: 137-144, 1989.
10. DAWSON, G. R. AND IVERSEN, S. D.: The effects of novel cholinesterase inhibitors and selective muscarinic agonists in tests of reference and working memory. Behav. Brain Res. 57: 143-153, 1993.
11. DIXON, W. J.: Analyses of extreme values. Ann. Math. Stat. 21: 488-506, 1959a.
12. DIXON, W. J.: Ratios involving extreme values. Ann. Math. Stat. 22: 68-78, 1959b.
13. DUBOIS, K. P. AND COTTER, G. J.: Studies on the toxicity and mechanism of action of dipterex. Arch. Indust. Health 11: 53-60, 1955.
14. DUNNETT, S. B., EVERITT, B. J. AND ROBBINS, T. W.: The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14: 494-501, 1991.
15. EGUCHI, J., YUASA, T., EGAWA, M. AND TOBE, A.: Effects of a novel compound MCI-225 on impaired learning and memory in rats. Pharmacol. Biochem. Behav. 48: 345-349, 1994.
16. ELLMAN, G. L., COURTNEY, K. D., ANDRES, V., JR. AND FEATHERSTONE, R. M.: A new, rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95, 1961.
17. FARLOW, M., GRACON, S. I., HERSHEY, L. A., LEWIS, K. W., SADOWSKY, C. H. AND DOLAN-URENO, J.: A controlled trial of tacrine in Alzheimer's disease. J. Am. Med. Assoc. 268: 2523-2529, 1992.
18. FIBIGER, H.: Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trends Neurosci. 14: 220-223, 1991.
19. FREUND, R. J. AND LITTELL, R. C.: SAS for linear models: A guide to the ANOVA and GLM procedures. SAS Institute Inc., Cary, NC, 1985.
20. GAMZU, E.: Animal behavioral models in the discovery of compounds to treat memory dysfunction. Ann. N. Y. Acad. of Sci. 444: 370-393, 1985.
21. GHEUSI, G., BLUTHE, R.-M., GOODALL, G. AND DANTZER, R.: Ethological study of the effects of tetrahydroaminoacridine (THA) on social recognition in rats. Psychopharmacology 114: 644-650, 1994.
22. GIACOBINI, E.: The cholinergic system in Alzheimer disease. Prog. Brain Res. 84: 321-332, 1990.
23. GIACOBINI, E.: The second generation of cholinesterase inhibitors: Pharmacological aspects. In Cholinergic Basis for Alzheimer Therapy, ed. by R. Becker and E. Giacobini, pp. 247-262, Birkhäuser, NY, 1991.
24. GROWDON, J. H.: Neurotransmitter precursors in the diet: Their use in the treatment of brain diseases. In Nutrition and the Brain, vol. 3, ed. by R. J. Wurtman and J. J. Wurtman, pp. 117-181, Raven Press, New York, 1979.
25. HAGAN, J. J., JANSEN, J. H. AND BROEKKAMP, C. L.: Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology 98: 347-356, 1989.
26. HALLAK, M. AND GIACOBINI, E.: A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology 26: 521-530, 1987.
27. HALLAK, M. AND GIACOBINI, E.: Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology 28: 199-206, 1989.
28. HINZ, V. C., BLOKLAND, A., VAN DER STAAY, F. J., GEBERT, I., SCHUURMAN, T. AND SCHMIDT, B. H.: Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents. Drug Dev. Res. 38, in press, 1996a.
29. HINZ, V., GREWIG, S. AND SCHMIDT, B. H.: Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem. Res. 21: 331-337, 1996b.
30. HINZ, V., GREWIG, S. AND SCHMIDT, B. H.: Metrifonate and dichlorvos: Effects of a single oral administration on cholinesterase activity in rat brain and blood. Neurochem. Res. 21: 339-345, 1996c.
31. HODGES, H., RIBEIRO, A. M., GRAY, J. A. AND MARCHBANKS, R. M.: Low dose of tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats. Pharmacol. Biochem. Behav. 36: 291-298, 1990.
32. HOLMSTEDT, B., NORDGREN, I., SANDOZ, M. AND SUNDWALL, A.: Metrifonate: Summary of toxicological and pharmacological information available. Arch. Toxicol. 41: 3-29, 1978.
33. ITOH, A., NITTA, A., HASEGAWA, T. AND NABESHIMA, T.: Effects of metrifonate on cholinesterase activity and the extracellular choline and acetylcholine levels in rodent brain. Jpn. J. Pharm. 67: suppl. I, 305, 1995.
34. JAEN, J. C. AND DAVIS, R. E.: Cholinergic therapies for Alzheimer's disease: Acetylcholinesterase inhibitors of current clinical interest. Curr. Op. in Invest. Drugs 2: 363-377, 1993.
35. JOHNSON, C. D. AND RUSSELL, R. L.: A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64: 229-238, 1975.
36. KUMAR, V. AND BECKER, R. E.: Clinical pharmacology of tetrahydroaminoacridine: A possible therapeutic agent for Alzheimer's disease. Int. J. Clin. Pharmacol. Ther. Tox. 27: 478-485, 1989.
37. KWO ON YUEN, P. F., MANDEL, R., CHEN, A. D. AND THAL, L. J.: Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Exp. Neurol. 108: 221-228, 1990.
38. MATSUOKA, N., MAEDA, N., OHKUBO, Y. AND YAMAGUCHI, I.: Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Res. 559: 233-240, 1991.
39. MOHAMMED, A. K., WAHLSTRÖM, G., ARCHER, T. AND NORDBERG, A.: Learning deficits in aged rats pretreated with barbital and tested late in abstinence: Alleviation by tetrahydroaminoacridine. J. Neural Transm. 2: 285-294, 1990.
40. MORRIS, R.: Development of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11: 47-60, 1984.
41. NABESHIMA, T., NITTA, A., ITOH, A., KATONO, Y. AND HASEGAWA, T.: Effects of metrifonate on impairment of learning, memory and acetylcholine release induced by scopolamine and basal forebrain lesion in rats (Abstract). Book of the 55th World Congress of Pharmacy and Pharmaceutical Science, Stockholm, August 28-September 1, 1995.
42. NIIGAWA, H., TANIMUKAI, S., TAKEDA, M., HARIGUSHI, S. AND NISHIMURA, T.: Effects of SDZ ENA 713, a novel acetylcholinesterase inhibitor, on learning of rats with basal forebrain lesions. Prog. Neuropsychopharm. Bio. Psych. 19: 171-186, 1995.
43. NORDGREN, L, BERGSTRÖM, M., HOLMSTEDT, B. AND SANDOZ, M.: Transformation and action of Metrifonate. Arch. Toxicol. 41: 31-41, 1978.
44. OGASAWARA, T., ITOH, Y., TAMURA, M., UKAI, Y., YOSHIKUNI, Y. AND KIMURA, K.: NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacol. Biochem. Behav. 83: 391-399, 1996.
45. OHNO, M., YAMAMOTO, T. AND WATANABE, S.: Involvement of cholinergic mechanisms in impairment of working memory in rats following basolateral amygdaloid lesions. Neuropharmacology 31: 915-922, 1992.
46. REINER, E. AND PLESTINA, R.: Regeneration of cholinesterase activities in humane and rats after inhibition of 0,0-dimethyl-2,2-dichlorovinyl phosphate. Toxicol. Appl. Pharmacol. 49: 451-454, 1979.
47. REINER, E., KRAUTHACKER, B., SIMEON, V. AND SKRINJARIC-SPOLJAR, M.: Mechanisms of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphate (Trichlorphon). Biochem. Pharmacol. 24: 717-722, 1975.
48. RIEKKINEN, P., JR., AALTONEN, M., SIRVIÖ, J. AND RIEKKINEN, P.: Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits. Physiol. Behav. 49: 1147-1152, 1991.
49. RIEKKINEN, P., JR., RIEKKINEN, M. AND SIRVIÖ, J.: Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats. Pharmacol. Biochem. Behav. 41: 637-641, 1992.
50. RIEKKINEN, P., JR., SIRVIÖ, J. AND RIEKKINEN, P.: The effects of THA on medial septal lesion-induced memory defects. Pharmacol. Biochem. Behav. 36: 237-241, 1990.
51. RITZMANN, R. F., KLING, A., MELCHIOR, C. L. AND GLASKY, A. J.: Effects of age and strain on working memory in mice as measured by win-shift paradigm. Pharmacol. Biochem. Behav. 44: 805-87, 1993.
52. ROGERS, S. L., YAMANISHI, Y. AND YAMATSU, K.: The pharmacology of a piperidine cholinesterase inhibitor. In Cholinergic basis for Alzheimer Therapy, ed. by R. Becker and E. Giacobini, pp. 314-320, Birkhäuser, Boston, 1991.
53. SOININEN, H., UNNI, L. AND SHILLCUTT, S.: Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochem. Res. 15: 1185-1190, 1990.
54. STERRI, S. H.: Factors modifying the toxicity of organophosphorus compounds including dichlorvos. Acta Pharmacol. Toxicol. 49: 67-71, 1981.
55. VAN DER STAAY, F. J., HINZ, V. C. AND SCHMIDT, B.: Effects of metrifonate on escape and avoidance learning in young and aged rats. Behav. Pharmacol. 7: 56-64, 1996.
56. VILLÉN, T., ADEN ABDI, Y., ERICSSON, O., GUSTAFSSON, L. L. AND SJÖQVIST, F.: Determination of metrifonate and dichlorvos in whole blood using gas chromatography and gas chromatography-mass spectrometry. J. Chromatogr. 529: 309-317, 1990.
57. VOLPE, L. S., BIAGIONI, T. M. AND MARQUIS, J. K.: In vitro modulation of bovine caudate muscarinic receptor number of organophosphates and carbamates. Toxicol. App. Pharmacol. 78: 226-234, 1985.
58. WEINSTOCK, M.: The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: An update. Neurodegeneration 4: 349-356, 1995.
59. WHALLEY, L. J.: Drug treatment of dementia. Br. J. Psychiatry 155: 595-611, 1989.
60. WOLTHUIS, O. L., GROEN, B., BUSKER, R. W. AND VAN HELDEN, H. P. M.: Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets. Pharmacol. Biochem. Behav. 51: 443-456, 1995.
61. YOSHIDA, S. AND SUZUKI, N.: Antiamnesic effects and cholinomimetic side-effects of the cholinesterase inhibitors physostigmine, tacrine and NIK-247 in rats. Eur. J. Pharmacol. 250: 117-124, 1993.